Different NP platforms such as micelles (Black et al., 2012), liposomes (Gadd et al., 2018), and polymeric NPs (Ilyinskii et al., 2014; Kim et al., 2018) have been established in recent studies for TLR7/8 agonist-based cancer vaccine. Here, TLR7 is linked to cancer.